Novo Nordisk moves to strengthen obesity efforts
pharmaphorum
JANUARY 17, 2022
Under the joint research plan, the Danish giant will work with EraCal to identify novel drug targets relevant for food intake regulation and additional metabolic phenotypes. Central nervous system-controlled behaviour, such as food intake, is notoriously difficult to explore in vitro.
Let's personalize your content